You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review

Article metrics

Article menu

Download PDFPDF

XML
Rheumatology
Research
Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review

 

Online download statistics by month:

Online download statistics by month: May 2019 to April 2024

AbstractFullPdf
May 201914514413
Jun 2019248237193
Jul 201911210732
Aug 2019888343
Oct 201912912631
Nov 2019545232
Dec 2019615729
Jan 2020515021
Feb 2020504621
Mar 2020322953
May 2020323117
Jun 2020444435
Jul 2020242412
Aug 2020181812
Sep 2020695619
Oct 2020454227
Nov 2020605218
Dec 2020484612
Jan 2021323116
Feb 2021201918
Mar 2021333216
Apr 2021484822
May 2021383516
Jun 2021413828
Jul 2021302716
Aug 2021201713
Sep 2021625735
Oct 2021332833
Nov 2021231722
Dec 202118156
Jan 202216179
Feb 2022222717
Mar 2022414118
Apr 2022666511
May 2022564819
Jun 2022322718
Jul 2022484717
Aug 2022423613
Sep 2022343332
Oct 2022372616
Nov 2022131012
Dec 202211104
Jan 202319177
Feb 202322217
Mar 2023262312
Apr 2023151211
May 2023121012
Jun 202314144
Jul 2023201912
Aug 202314129
Sep 2023262316
Oct 202325217
Nov 2023261710
Dec 202339328
Jan 202431288
Feb 202421209
Mar 2024272249
Apr 20248712
Total247122931240